Logo for Sonnet BioTherapeutics Holdings Inc

Sonnet BioTherapeutics Holdings Investor Relations Material

Latest events

Logo for Sonnet BioTherapeutics Holdings

Q1 2025

13 Feb, 2025
Logo for Sonnet BioTherapeutics Holdings

Investor Presentation

28 Jan, 2025
Access the full event backlog
Slides, Transcripts, and Reports from 12,000+ public companies

Latest reports from Sonnet BioTherapeutics Holdings Inc

Access all reports
Sonnet BioTherapeutics Holdings Inc is a U.S.-based clinical-stage biopharmaceutical company focused on the development of innovative biologic drugs for cancer and other serious diseases. The company utilizes a proprietary platform to design fully human fusion proteins that enhance the therapeutic activity and delivery of cytokines. Sonnet’s pipeline targets various solid tumors and immunological conditions, with development efforts supported by preclinical and clinical research. The company is headquartered in Princeton, New Jersey, and its shares are listed on the NASDAQ.